{"id":"W4392631890","doi":"10.1136/ijgc-2024-esgo.584","title":"176 Rucaparib maintenance treatment in patients (Pts) with newly diagnosed ovarian cancer (OC): defining benefit according to disease risk subgroups within the phase 3 ATHENA-MONO study","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Oncology; Population; Placebo; Stage (stratigraphy); Chemotherapy; Ovarian cancer; Cancer; Surgery; Gynecology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00122732,0.0003981006,0.001251649,0.0003106573,0.0002040321,0.000771602,0.0002680465,0.0004475878,0.001456433],"category_scores_gemma":[0.001238966,0.0002155561,0.001333816,0.0004206137,0.0002314058,0.0004588618,0.0002792208,0.0009491882,0.0002197593],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004899631,"about_ca_system_score_gemma":0.000487021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007887401,"about_ca_topic_score_gemma":0.003383933,"domain_scores_codex":[0.9994882,0.0002748381,0.00003393243,0.00007988853,0.00005311958,0.00006991286],"domain_scores_gemma":[0.9995148,0.0001868032,0.0001220516,0.0000444072,0.0000267924,0.0001051384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7061475,0.003007344,0.1271308,0.0007870626,0.006872999,0.0001045094,0.0001833505,0.001577077,0.009595968,0.0003668554,0.003098861,0.1411277],"study_design_scores_gemma":[0.2142019,0.1327254,0.6310135,0.0002055421,0.0073831,0.0003608261,0.0002269715,0.002972263,0.00199109,0.00103877,0.007793684,0.00008695851],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934351,0.004067356,0.0001869414,0.0001802395,0.00004355624,0.0001973271,0.0006598652,0.00001373088,0.001215877],"genre_scores_gemma":[0.9968262,0.0008416172,0.0003632468,0.0003249033,0.00005302015,0.0001458454,0.0009856288,0.000005056374,0.0004545818],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001456433,"threshold_uncertainty_score":0.006490767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02559736903672858,"score_gpt":0.3509724077453201,"score_spread":0.3253750387085915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}